DPP-4 Inhibitor for the Treatment of Type 2 Diabetes and Intellectual Property Analysis
- VernacularTitle:治疗2型糖尿病的DPP-4抑制药及其知识产权分析
- Author:
Xu YONG
;
Huang LU
;
Yang JING
;
Liu QUAN
;
He WEN
- Publication Type:Journal Article
- Keywords:
DPP-4 inhibitors;
Type 2 diabetes;
Intellectual property;
Analysis;
Patent information;
Generics
- From:
China Pharmacist
2015;(2):301-306
- CountryChina
- Language:Chinese
-
Abstract:
DPP-4 inhibitors are new oral hypoglycemic drugs and hot spots developed and launched in recent years, and they pro-vide new choices for the clinical treatment of type 2 diabetes. In China, DPP-4 inhibitors that are approved to use in the treatment of type 2 diabetes are all imported products currently. In the paper, the current intellectual property situation of DPP-4 inhibitors that are developed and approved at home and abroad is researched and analyzed. Reasonable use of the patent information of DPP-4 inhibitors that is about to expire or have failed can provide good guidance for the subsequent development of DPP-4 inhibitors in domestic with promising curative effect and good market prospects, and can generate new patents in order to enhance the market competitiveness.
